Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

Molecular pharmacology and modeling of vasopressin receptors.

Thibonnier M, Coles P, Thibonnier A, Shoham M.

Prog Brain Res. 2002;139:179-96. Review.

PMID:
12436935
3.

Multiple mechanisms involving protein phosphorylation are linked to desensitization of muscarinic receptors.

Hosey MM, Benovic JL, DebBurman SK, Richardson RM.

Life Sci. 1995;56(11-12):951-5. Review.

PMID:
10188798
4.

Desensitisation of the oxytocin receptor and other G-protein coupled receptors in the human myometrium.

Plested CP, Bernal AL.

Exp Physiol. 2001 Mar;86(2):303-12. Review.

PMID:
11429648
5.

Oxytocin receptors: ligand binding, signalling and cholesterol dependence.

Gimpl G, Reitz J, Brauer S, Trossen C.

Prog Brain Res. 2008;170:193-204. doi: 10.1016/S0079-6123(08)00417-2. Review.

PMID:
18655883
6.

Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors.

Thibonnier M, Berti-Mattera LN, Dulin N, Conarty DM, Mattera R.

Prog Brain Res. 1998;119:147-61. Review.

PMID:
10074787
7.

Agonist binding to peptide hormone receptors.

Wheatley M, Hawtin SR, Wesley VJ, Howard HC, Simms J, Miles A, McEwan K, Parslow RA.

Biochem Soc Trans. 2003 Feb;31(Pt 1):35-9. Review.

PMID:
12546649
8.

Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.

Postina R, Kojro E, Fahrenholz F.

Adv Exp Med Biol. 1998;449:371-85. Review.

PMID:
10026828
9.

Vasopressin and oxytocin receptors in the central nervous system.

Barberis C, Tribollet E.

Crit Rev Neurobiol. 1996;10(1):119-54. Review.

PMID:
8853957
10.

Structural bases of vasopressin/oxytocin receptor function.

Barberis C, Mouillac B, Durroux T.

J Endocrinol. 1998 Feb;156(2):223-9. Review. No abstract available.

11.

Molecular evolution of ligand-binding specificity in the vasopressin/oxytocin receptor family.

van Kesteren RE, Geraerts WP.

Ann N Y Acad Sci. 1998 May 15;839:25-34. Review. No abstract available.

PMID:
9629128
12.

Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins.

Iacovelli L, Sallese M, Mariggiò S, de Blasi A.

FASEB J. 1999 Jan;13(1):1-8. Review.

13.

Structure and mechanism of the G protein-coupled receptor kinases.

Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ.

J Biol Chem. 1993 Nov 15;268(32):23735-8. Review. No abstract available.

14.

Thrombin receptors: turning them off after turning them on.

Brass LF, Ahuja M, Belmonte E, Blanchard N, Pizarro S, Tarver A, Hoxie JA.

Semin Hematol. 1994 Jul;31(3):251-60. Review.

PMID:
7973781
15.

Differential down-regulation of alpha-2 adrenergic receptor subtypes.

Heck DA, Bylund DB.

Life Sci. 1998;62(17-18):1467-72. Review.

PMID:
9585120
16.

Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.

Cottet M, Albizu L, Perkovska S, Jean-Alphonse F, Rahmeh R, Orcel H, Méjean C, Granier S, Mendre C, Mouillac B, Durroux T.

Curr Opin Pharmacol. 2010 Feb;10(1):59-66. doi: 10.1016/j.coph.2009.10.003. Review.

PMID:
19896898
17.

[The molecular determinants of receptors and GTP-binding proteins that define the specificity of the interactions between them].

Shpakov AO.

Zh Evol Biokhim Fiziol. 1996 Jul-Aug;32(4):488-510. Review. Russian. No abstract available.

PMID:
9054181
18.

Molecular basis of ligand binding and receptor activation in the oxytocin and vasopressin receptor family.

Chini B, Fanelli F.

Exp Physiol. 2000 Mar;85 Spec No:59S-66S. Review.

PMID:
10795907
19.

[Some newer findings concerning oxytocin receptor signaling].

Klenerová V, Hynie S.

Cesk Fysiol. 2008;57(2-3):76-82. Review. Czech.

PMID:
19323417
20.

Insights into the molecular evolution of oxytocin receptor ligand binding.

Koehbach J, Stockner T, Bergmayr C, Muttenthaler M, Gruber CW.

Biochem Soc Trans. 2013 Feb 1;41(1):197-204. doi: 10.1042/BST20120256. Review.

Items per page

Supplemental Content

Support Center